CEL-SCI CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
CEL-SCI CORPORATION (CVM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-14
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 0.00 shares.
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-06-30 was 905.00 shares, a 45150.00% increase year-over-year.
- CEL-SCI CORPORATION share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-03-31 was 0.00 shares, a 100.00% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-14 | 0.00 shares 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-15 | 0.00 shares 10-Q · filed 2026-05-15 | ||||
| 2025-06-30 | 905.00 shares 10-Q · filed 2026-08-14 | 905.00 shares derived: sum of 2 quarters · filed 2026-08-14 | 906.00 shares 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-15 | 2.00 shares 10-Q · filed 2026-05-15 | 40.00 shares 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | 2.00 shares 10-Q · filed 2026-02-17 | 40.00 shares 10-Q · filed 2025-02-14 | ||||
| 2024-06-30 | 2.00 shares 10-Q · filed 2025-08-14 | 40.00 shares 10-Q · filed 2024-08-14 | 27.04K shares derived: sum of 2 quarters · filed 2025-08-14 | 903.00 shares 10-Q · filed 2025-08-14 | 27.07K shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 27.04K shares 10-Q · filed 2025-05-14 | 27.04K shares 10-Q · filed 2025-05-14 | ||||
| 2023-12-31 | 0.00 shares 10-Q · filed 2025-02-14 | |||||
| 2023-06-30 | 13.38M shares 10-Q · filed 2024-08-14 | 13.38K shares 10-Q · filed 2023-08-10 | 13.39M shares derived: sum of 2 quarters · filed 2024-08-14 | 58.79K shares 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | 4.00K shares 10-Q · filed 2024-05-15 | 4.00 shares 10-Q · filed 2023-05-12 | 45.40K shares 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | 45.40K shares 10-Q · filed 2024-02-14 | |||||
| 2022-06-30 | 13.61K shares 10-Q · filed 2023-08-10 | 13.61K shares derived: sum of 2 quarters · filed 2023-08-10 | 13.61K shares 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-13 | 0.00 shares 10-Q · filed 2022-05-13 | ||||
| 2021-12-31 | 0.00 shares 10-Q · filed 2022-02-11 | |||||
| 2021-06-30 | 9.31K shares 10-Q · filed 2022-08-12 | 9.32K shares derived: sum of 2 quarters · filed 2022-08-12 | 9.37K shares 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | 12.00 shares 10-Q · filed 2022-05-13 | 67.00 shares 10-Q · filed 2022-05-13 | ||||
| 2020-12-31 | 55.00 shares 10-Q · filed 2022-02-11 | |||||
| 2020-06-30 | 16.00 shares 10-Q/A · filed 2020-12-31 | 1.15K shares derived: sum of 2 quarters · filed 2021-05-17 | 1.18K shares 10-Q · filed 2021-08-13 | 1.00K shares 10-Q/A · filed 2020-08-11 | ||
| 2020-03-31 | 1.13K shares 10-Q · filed 2021-05-17 | 1.17K shares 10-Q · filed 2021-05-17 | ||||
| 2019-12-31 | 36.00 shares 10-Q · filed 2021-02-12 | |||||
| 2019-06-30 | 26.92K shares 10-Q/A · filed 2020-12-31 | 26.92K shares derived: sum of 2 quarters · filed 2020-12-31 | 29.32K shares 10-Q/A · filed 2020-12-31 | |||
| 2019-03-31 | 0.00 shares 10-Q/A · filed 2020-12-30 | 2.40K shares 10-Q/A · filed 2020-12-30 | ||||
| 2018-12-31 | 2.40K shares 10-Q/A · filed 2020-12-30 | |||||
| 2018-06-30 | 2.02K shares 10-Q · filed 2019-08-14 | 2.60K shares derived: sum of 2 quarters · filed 2019-08-14 | 26.39K shares 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | 584.00 shares 10-Q · filed 2019-05-14 | 24.38K shares 10-Q · filed 2019-05-14 | ||||
| 2017-12-31 | 17.52K shares 10-Q · filed 2019-02-14 | |||||
| 2017-06-30 | 800.00 shares 10-Q · filed 2018-08-14 | 1.00K shares derived: sum of 2 quarters · filed 2018-08-14 | 16.08K shares 10-Q · filed 2018-08-14 | |||
| 2017-03-31 | 200.00 shares 10-Q · filed 2018-05-15 | 5.00K shares 10-Q · filed 2017-05-10 | 15.28K shares 10-Q · filed 2018-05-15 | 382.04K shares 10-Q · filed 2017-05-10 | ||
| 2016-12-31 | 15.08K shares 10-Q · filed 2018-02-12 | 377.04K shares 10-Q · filed 2017-02-09 | ||||
| 2016-06-30 | 0.00 shares 10-Q/A · filed 2017-12-11 | 0.00 shares derived: sum of 2 quarters · filed 2017-12-11 | 0.00 shares 10-Q/A · filed 2017-12-11 | |||
| 2016-03-31 | 0.00 shares 10-Q/A · filed 2017-12-11 | 0.00 shares 10-Q/A · filed 2017-12-11 | ||||
| 2015-12-31 | 0.00 shares 10-Q/A · filed 2017-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |